Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data

INTENDED LEARNERS
This activity is designed for general and specialty neurologists, psychiatrists, neurology and psychiatric NPs, advanced practice nurses (APRNs), PAs, nurses, and other healthcare practitioners who care for patients with early AD.

LEARNING OBJECTIVES
After participating in this activity, learners should be better able to:

• Describe future clinical uses for disease-modifying treatments for early AD
• Summarize efficacy and safety data for emerging AD medications

COMMERCIAL SUPPORT
NACCME would like to thank the following company who has supported "Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data" through educational grants and/or in-kind support: Biogen

CLAIMING CREDIT
To be eligible for credit, participants must complete the online activity and the evaluation. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.

CONTINUING EDUCATION

In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS
NACCME designates this internet enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING
This continuing nursing education activity awards 0.25 contact hour.

PHYSICIAN ASSISTANTS
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.

FOR MORE INFORMATION ABOUT THIS TRAINING CLICK HERE